Pillar · Biotech Investing
Biotech Due Diligence Checklist: How to Evaluate a Drug Pipeline and Probability of Approval
Most biotech investors skip due diligence and pay the price. This step-by-step checklist walks you through everything yo...
Start here
Pillar · Clinical Readouts
How to Read Biotech Clinical Trial Data: Phase 1, 2, 3 Results Explained for Investors
Clinical trial data is the single most important factor in biotech investing, but most investors struggle to read it. Th...
Therapeutic Areas
Navigating Biotech Stock Catalysts: Insights from Clinical Phases and Therapeutic Areas
Discover the latest trends and investor insights into biotech stocks, exploring average stock price changes by therapeutic area and clinical phase, and historic...
FDA & PDUFA Calendar
Biotech Mid 2025 Catalysts: Nimacimab, Afrezza, VX-522, SGT-003 & More In Focus
Discover mid 2025 catalyst events in biotech: Skye Bioscience’s nimacimab, MannKind’s inhaled insulin Afrezza, Vertex’s VX-522 mRNA therapy, Solid’s SGT-003, Un...
Clinical Readouts
Phase 2 Biotech Catalysts to Watch This Week (June 12–16, 2025)
This week is packed with high-stakes biotech news as six companies release pivotal Phase 2 clinical trial data. From oncology to rare diseases and chronic condi...
FDA & PDUFA Calendar
Key FDA Decisions Approaching in April 2025 (PDUFA Date Calendar)
April 2025 is a key month for biotech and pharma, with the FDA set to make decisions on several significant drug applications. These decisions cover new formula...
FDA & PDUFA Calendar
FDA Drug Approval Process
The FDA drug approval process ensures that new medications are safe, effective, and meet rigorous scientific standards before reaching the market. This multi-ph...
Catalyst Analysis
Our Top 10 BioPharma Stocks from Q2 BioHedge Funds Data!
Return from August 15, 2024: +11.41% 🚀 Return for the Last 1 Month: +12.63%✅ Return for the Last 1 Year: +111.97%💯 Hey everyone, we've analyzed data from ...
FDA & PDUFA Calendar
August 2024 PDUFAs Drug Approval Outlook
Let's dive into the most anticipated PDUFA dates and see what our crystal ball (and some solid data) tells us about their approval chances. Plus, we'll see how ...
FDA & PDUFA Calendar
Top 10 Potential Biotech buyout in 2024
The biotech and pharmaceutical industries are constantly evolving, with mergers and acquisitions (M&A) serving as key catalysts for change, innovation, and grow...
FDA & PDUFA Calendar
Biotech Stock Catalysts and PDUFA Dates: The Pharma Watch List for Investors
A biotech catalyst watch list is a dated list of events that can revalue a company in one session. This guide covers which catalyst types are worth tracking, ho...